Retrospective Follow-up of Synvisc® in Active Patients With Knee Osteoarthritis

Retrospective collection of data, aimed at a better knowledge of the context of use of Synvisc® among the patients practising a regular activity (professional/leisure), and at evaluating the different practices and their results.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Osteoarthritis Arthritis Joint Diseases Musculoskeletal Diseases Rheumatic Diseases

Sex eligibility

All sexes

Study type

Observational

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

use of Synvisc®
patients practising a regular activity (professional/leisure)

Exclusion criteria

none

Treatment and study plan

Synvisc®

Drug

Primary outcomes

Amount of medication consumed

Time frame: up to 1 year

antalgics, non-steroid anti-inflammatory drugs (NSAIDs), steroid anti-inflammatory drugs (SAIDs)

Secondary outcomes

Patient-assessed benefit on a 2-point verbal rating scale

Time frame: up to 1 year

Sponsors and collaborators

Lead sponsor

Boehringer Ingelheim

Industry

Registry information

Official study title

Synvisc® in With Knee Osteoarthritis: Retrospective Follow-up in Active Patients

Important dates

Study start: 2002
Primary completion: 2003
First posted: Jul 21, 2014
Registry last updated: Jul 21, 2014

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed